Delivery Order SPE2DE23D0008-SPE2D626F05BT
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on November 18, 2025, for Natrelle Inspira SSM 255CC breast implants. This delivery order, issued without set-aside designation, is scheduled for completion by December 3, 2025, and represents a child contract under one of Allergan's two significant Indefinite Delivery/Indefinite Quantity contracts with the Defense Logistics Agency Troop Support Medical. The $13.5 million IDV for Natrelle breast...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,300.00 on December 11, 2025, for Natrelle Inspira SSM 520CC breast implants. This delivery order represents a child contract under one of Allergan's existing Indefinite Delivery/Indefinite Quantity (IDV) vehicles—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established with the Defense Logistics Agency Troop Support Medical on December 8, 2022. The...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,814 delivery order for Natrelle Inspira SCF 485CC breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment was awarded on December 9, 2025, with an ultimate completion date of December 11, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as the sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,228.00 fixed-price delivery order with economic price adjustment on December 9, 2025, for Natrelle Inspira SCF 385CC breast implants. The contract, which is expected to be completed by December 11, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order carries no set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F05BTDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order with economic price adjustment on December 11, 2025, for Natrelle Inspira SSM 310CC breast implants. The contract, with an ultimate completion date of December 15, 2025, represents a child delivery order under one of Allergan's two significant Indefinite Delivery/Indefinite Quantity (IDV) contracts with the Defense Logistics Agency Troop Support Medical. Specifically, this order falls under the $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. The contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and involves performance at Allergan's location in Irvine, California. No set-aside designation was used for this award. The delivery order supports the provision of specialized reconstructive and aesthetic surgical supplies to military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. Allergan's status as a sole-source provider of these medical devices is reflected in the absence of set-aside designations across its recent federal contract awards. The fixed-price structure with economic price adjustment pricing mechanism reflects standard procurement practices for specialized medical devices supplied through the Defense Logistics Agency, ensuring cost certainty while allowing for adjustments based on economic factors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/10/25 |